ndian pharmaceutical stocks dropped sharply on Tuesday after U.S. President Donald Trump signed an executive order aimed at boosting domestic drug manufacturing, raising concerns about potential challenges for Indian exporters heavily dependent on the U.S. market.
Comments
Post a Comment